AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit
Researchers at the Netherlands Cancer Institute have developed an AI model called ARTIMES to improve the assessment of pleural mesothelioma tumors. The model measures tumor volume more accurately than traditional diameter-based methods, leading to better treatment outcomes.
Why it matters
AI-driven diagnostic tools can significantly improve the reliability of clinical trials and the precision of cancer treatments for patients with complex tumor types.
edited by Sadie Harley , reviewed by Robert Egan
The article reports on medical research developments using objective, evidence-based language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in